The class II BF-37°C-2D22-NGC structure may represent a structure trapped at an intermediate stage of expansion at 37°C. Previous cryo-EM studies of the uncomplexed 37°C DENV2(NGC) sample showed four stages of structural change (9) , of which only stage 1 and 3 structures were interpreted. The first stage is similar to the unexpanded structure. The third stage showed that all dimers had moved to a higher radius. The A-C dimer rotated, whereas the B-B′ dimer dissociated from each other. Comparison of the class II BF-37°C-2D22-NGC structure with the DENV2 37°C stage 3 structure (Fig. 3B, ii) showed similar organization to that of the A-C dimers. The B-B′ dimer, on the other hand, seemed to be a transitional structure between the DENV2 NGC 37°C stage 1 and 3 structure, as it lay at a radius in between these two structures (Fig. 3B, i and ii).
The~21 Å resolution class II AF-37°C-2D22-NGC cryo-EM map (Fig. 4, A and B, and fig. S10 ) showed clear Fab densities near the fivefold vertices and much weaker Fab densities near the threefold vertices. The E protein densities were sparse; therefore, the map was not interpreted. The positions of Fab density near the fivefold vertices was similar to those in the BF-37°C-2D22-NGC map, but not those near the threefold vertices. The Fab densities near the fivefold and threefold vertices probably represent those that are bound to each end of the A-C′ dimer. Neutralization profiles of BF-37°C-2D22-NGC and AF-37°C-2D22-NGC samples were similar (fig. S12B), suggesting that the poor Fab density near the threefold vertices may be due to local movement in the structure rather than low Fab occupancy.
DENV fusion in endosomes requires E protein dimers to disassociate and then reassociate into trimeric structures. Fab 2D22 locks both ends of all dimers on DENV2(PVP94/07), thereby preventing E protein reorganization. In the BF-37°C-2D22-NGC and AF-37°C-2D22-NGC samples, only twothirds of the dimers on the virus surface are locked. The remaining free dimer in each raft is probably unable to form trimers. Indeed, HMAb 2D22 effectively neutralized DENV2 strains PVP94/07 and NGC, even though the latter bound one-third fewer antibody molecules ( fig. S12A ).
Many human antibodies that strongly neutralize dengue bind to quaternary epitopes (epitopes involving more than one E protein molecule) (6, 11, 12) . Human antibodies that neutralize DENV serotypes 1 and 3 bound to quaternary epitopes, which require virion assembly (11, 12) . In contrast, HMAb 2D22 binds to a simpler epitope that requires only the formation of E homodimers. Several DENV serotype cross-neutralizing human antibodies (13) were also shown to bind E protein dimer epitope (EDE) ( fig. S13 , B, C, and D). These EDEs are largely similar to 2D22 epitope ( fig. S13 , A, B and C). Compared to HMAb C8 and C10 ( fig. S13 , A, B, and C), HMAb 2D22 has more interactions on DIII that are unique to DENV2 ( fig. S13E ), leading to its serotype specificity.
The DENV2 surface is more dynamic than that of the other serotypes (9, 10) . Thus, antibodies that bind across different dimers and rafts may lose potency, depending on the temperature and strain of DENV2. Therefore, antibodies binding to "simpler" epitopes, such as monomers or dimers, may be more effective against this serotype.
In areas of high dengue endemicity, a potential therapeutic needs to be protective in the presence of preexisting antibodies (14) . Certain MAb LALA variants protect therapeutically against an ADE infection, because they are neutralizing and at the same time suppress the enhancing potential of preexisting fusion loop antibodies by displacing their binding (15) (16) (17) . In contrast, highly neutralizing DIII MAbs that do not block fusion loop enhancing antibodies protect in high-dose-DENV2-lethal, but not ADE-DENV2-lethal challenge (Fig. 1C) (17) . The increased efficacy of HMAb 2D22 may be due to its ability to lock E proteins and also block the binding of low-affinity fusionloop enhancing antibodies.
The molecular features of the 2D22 epitope and the ability of HMAb 2D22-LALA to prevent ADE will aid in the development of vaccines and therapeutics, respectively. Pang-Hung Hsu, 4 Hsueh-Chi S. Yen 1,2 * Selenocysteine (Sec) is translated from the codon UGA, typically a termination signal. Codon duality extends the genetic code; however, the coexistence of two competing UGA-decoding mechanisms immediately compromises proteome fidelity. Selenium availability tunes the reassignment of UGA to Sec. We report a CRL2 ubiquitin ligase-mediated protein quality-control system that specifically eliminates truncated proteins that result from reassignment failures. Exposing the peptide immediately N-terminal to Sec, a CRL2 recognition degron, promotes protein degradation. Sec incorporation destroys the degron, protecting read-through proteins from detection by CRL2. Our findings reveal a coupling between directed translation termination and proteolysis-assisted protein quality control, as well as a cellular strategy to cope with fluctuations in organismal selenium intake.
T he canonical genetic code includes 20 amino acids. Additionally, selenocysteine (Sec/U) and pyrrolysine (Pyl/O) are the 21st and 22nd amino acids and are coded by the otherwise termination codons UGA and UAG, respectively (1, 2). Sec is cotranslationally incorporated into selenoproteins, a distinct set of proteins largely functioning as oxidoreductases, with Sec in the active sites (3-5). At least 25 selenoproteins have been identified in humans SCIENCE sciencemag.org (6) . Translating UGA into Sec requires a Sec insertion sequence (SECIS) element in the 3′ untranslated region (3′UTR) of mRNA transcripts, Sec-transfer RNA (tRNA), Sec-specific elongation factor (eEFSec), and the SECIS-binding protein SBP2 (7) (8) (9) (10) . This renders UGA/Sec redefinition failure-prone, facing competition between SectRNA and the release factor for UGA decoding (11) . The reassignment efficiency is greatly influenced by dietary selenium (12) . Stop codon reprograming expands the genetic code at the risk of introducing premature translational termination due to missed stop codon reassignment. Cells process potentially detrimental truncated proteins produced from failed UGA-to-Sec translation via previously undetermined mechanisms.
We developed GPS, a cell-based system for measuring global protein stability (13) . In this system, the expression cassette contains a single promoter with an internal ribosome entry site, permitting the expression of two fluorescent proteins from one mRNA transcript. The first fluorescent protein, RFP (red fluorescent protein), is the internal control, whereas the second fluorescent protein GFP (green fluorescent protein) is fused to the N terminus of the protein of interest. The GFP/RFP ratio is a surrogate for protein stability measurements reading the relative steady-state abundance of GFPfusion protein over RFP (13, 14) . Coupling GPS with functional ablation of ubiquitin ligase, we generated a generic platform to isolate ubiquitin ligase substrates (14, 15) . This strategy identified 102 substrates for the CRL2 ubiquitin ligase, including the five selenoproteins SEPHS2, SELV, SEPX1/MSRB1, SELK, and SELS/VIMP from a GPS library containing 15 ,483 human open reading frames (ORFs) (fig. S1, A and B) . We subcloned these selenoprotein genes into backgrounds resembling native transcripts (+UTR, Fig. 1D ). Inhibition of CRL2 activity by either genetic perturbation or pharmacological treatment stabilized these selenoproteins, but not their paralogs without Sec (SEPHS1 and SEPW2) (Fig. 1A  and fig. S1 , C and D). The stability of selenoproteins was positively correlated with selenium availability (Fig. 1B) ; selenium supplementation attenuated CRL2-mediated selenoprotein degradation (Fig. 1C) .
The five selenoproteins identified share no sequence similarity ( fig. S1E ). We generated various selenoprotein mutants to uncover the determinants for their degradation (Fig. 1D) . Analysis of selenoprotein constructs exclusively expressing truncated proteins (DUTR, D, UAA, and UAG) and those producing only full-length (FL) proteins via replacement of UGA to other codons, revealed that CRL2 selectively targeted truncated but spared FL selenoproteins (Fig. 1, E  and F, and fig. S2, A and B) .
We asked whether CRL2 is responsible for removing prematurely terminated selenoproteins arising from failures in UGA/Sec reprograming. FL selenoproteins were more stable than truncated ones (Fig. 2A) ; the stability of selenoproteins expressed from the UTR construct fell in between, as expected from a mixture of FL and truncated proteins. Indeed, two populations of proteins were translated from the UTR-containing mRNAs upon CRL2 suppression: a shorter product terminated at the UGA codon and a longer read-through product, with the former as the only CRL2 substrate (Fig. 2B ). Similar to FL selenoproteins created by substituting the UGA codon (Fig. 1, E and F) , Sec-containing FL selenoproteins were stable and exempted from CRL2 surveillance (Fig. 2C  and fig. S2C ). Selenium availability had no effect on the stability of truncated or FL selenoproteins ( fig. S2D) Sec insertion (Fig. 2D) . The accumulation of truncated selenoproteins was heightened by CRL2 inhibition, regardless of the selenium supplies (Fig. 2D and fig. S2E ). Endogenously made truncated selenoproteins were accumulated upon CRL2 inhibition ( fig. S3 ). Taken together, these results reveal a role of CRL2 as a gatekeeper in selenoprotein quality control.
CRL2 can recognize truncated SELK and SELS, even though these two proteins differ from their FL counterparts by only three or two amino acids, respectively ( fig. S1E ). CRL2 may recognize truncated selenoproteins by sensing incomplete translation via scouting the UTR of mRNA transcripts. Alternatively, components in Sec incorporation machinery may assist CRL2 to distinguish UGA-terminated selenoproteins. However, selenoproteins expressed from constructs lacking 3′UTRs or sequences 3′ to UGA remained CRL2 substrates (Fig. 1, E and F) . Protein half-lives of truncated selenoproteins from transcripts with or without 3′UTR were comparable ( fig. S4A) . Moreover, knocking down SBP2 or eEFSec, which are trans-acting elements essential for Sec incorporation, decreased Sec insertion efficiency but did not influence CRL2-mediated degradation (Fig. 2, E and F) . To examine whether CRL2-mediated degradation exhibits substrate specificity, we created artificial selenoproteins; CRL2 could not target UGA-terminated glyceraldehyde phosphate dehydrogenase (GAPDH) made from GAPDH transcripts with in-frame UGA codons within the ORF and 3′UTR from authentic selenoproteins (Fig. 2, G and H) . Collectively, our data support the notion of direct recognition of truncated protein products by CRL2.
We systematically shortened (-) or extended (+) the length of the UGA-terminated selenoprotein (D) to elucidate how CRL2 recognized truncated selenoproteins. Truncations had to be made at the position within one to two amino acid residues originally translated into Sec so as to promote CRL2-mediated degradation (Fig. 3,  A and B, and fig. S4B ). A 12-residue C-terminal tail (CTT) of UGA-terminated selenoproteins was sufficient to promote CRL2-mediated degradation (Fig. 3C and fig. S5, A and B) . Fusion of CTTs to GAPDH and RAN, which are not natural CRL2 substrates, resulted in their degradation by CRL2 (Fig. 3, D and E) . Thus, CTTs comprise transferable CRL2 degrons (degradation signals). The minimal CRL2 degrons can be as small as 10 or 7 residues in length (Fig. 3F) .
We identified a critical glycine at the -1 position of SELK and SELS, or at the -2 position of SELV (Fig. 3C) . Replacing this glycine with other amino acids abolishes CRL2-dependent degradation (Fig. 3G and fig. S5B ). Changing the leucine at the -1 position of SELV, next to this glycine, did not affect SELV degradation (fig. S5C) . The residues C-terminal to Sec, covering the degron, can tolerate more extreme replacement ( fig. S5D ). Fusing the C-terminal end of UGA-terminated selenoproteins to GFP fully abrogated selenoprotein degradation ( fig. S5E ). An illegitimate C terminus, once exposed, triggers CRL2-mediated selenoprotein quality control. Rather than serving as a general inspector to eliminate every abnormal selenoproteins, CRL2 mediates the degradation to clear truncated translational products of unsuccessful UGA-to-Sec decoding.
CRL2 is a modular ubiquitin ligase that uses an interchangeable set of BC-box proteins as substrate receptors when forming approximately 40 different CRL2 complexes with a host of substrate specificities (16) (17) (18) (19) . We found that CRL2 targeted various UGA-terminated selenoproteins via distinct BC-box proteins (Fig. 4,  A and B, and fig. S6 ). KLHDC3, APPBP2, and KLHDC2 were used to target SEPHS2, SELV and SELK, respectively; SELS could be targeted by both KLHDC2 and KLHDC3. SEPX1 could be recognized by four BC-box proteins, namely PRAME, PRAMEF6, PRAMEF9, and FEM1C. Each BC-box protein was preferentially associated with the corresponding UGA-terminated selenoprotein over the FL one (Fig. 4C and fig.  S6, D and E) . Furthermore, the substrate selectivity of CRL2 was attributed to BC-box proteins (Fig. 4, D and E) . Supporting the idea that CTTs comprise CRL2 degrons, GAPDH-CTT fusions confer binding to the acceptor BC-box proteins (Fig. 4F) . Swapping respective BC-box proteins can be achieved by exchanging CTTs or adding an extra CTT C-terminal to UGA-terminated selenoprotein (Fig. 4G and fig. S7A ).
In examining the prevalence of proteolysisassisted selenoprotein quality control, we detected CRL2-mediated quality surveillance for SEPHS2, SELV, SEPX1, SELK, and SELS in all cell types tested (Fig. 4H and fig. S8A ). We surveyed six additional selenoproteins and identified one more CRL2 substrate, SEPW1. CRL2 also selectively degraded the UGA-terminated version of SEPW1 while sparing the read-through version ( fig. S8B) . Regardless of the involvement of CRL2, FL selenoproteins were more stable than their truncated counterparts, and truncated proteins were degraded by the ubiquitin-proteasome pathway ( fig. S8, C and D) .
When selenium is limited, the transcripts of some, but not all, selenoproteins are driven toward degradation by the nonsense-mediated mRNA decay pathway (20) (21) (22) . CRL2 provides an additional layer of defense against translational errors due to the duality in codon assignment. The tiered and complementary nature of these two safeguards grants robustness and fidelity to selenoprotein quality control. Here we report a mechanism by which CRL2 recognizes aberrant selenoproteins via various substrate receptors. We have allocated the peptide immediately N-terminal to Sec as the CRL2-targeting degron triggering degradation when placed at the C-terminal end of a protein (fig. S9A ). The CRL2 degrons are highly conserved across species ( fig. S9B) . The BC-box proteins responsible for selenoprotein recognition do not share common substrate recognition motifs. Instead, they contain various structural motifs involved in general protein-protein interaction, such as Kelch, LRR, ANK, and TPR repeats ( fig. S7B) . APPBP2, KLHDC2, KLHDC3, PRAME, and FEM1C have all been implicated in human diseases, although selenoproteins are their only identified substrates to date. Beyond exclusively serving as selenoproteinspecific inspectors, these CRL2 substrate receptors may play a broader role in targeted protein degradation.
